Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review. - Wikidata - wikimedia - TriplyDB

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

http://www.wikidata.org/entity/Q34961901

about

High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer Emerging drugs for chronic obstructive pulmonary disease.Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?Emerging pharmaceutical therapies for COPD.The Use of Chinese Herbal Medicine in the Treatment of Chronic Obstructive Pulmonary Disease (COPD).The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling.Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis

P2860

Q35070914-C26561FA-3D6E-4433-BB4D-E65E5D062135 Q36384591-2C4ED0A8-CA9B-43F3-8103-AE225034CDA5 Q36834005-F8CF617B-A09A-492F-BA51-A53D66441E3B Q37984088-6896716E-57F2-420D-8A74-71D74E68BB04 Q38270131-4197754B-F996-4C1E-9596-2292402696CC Q38645203-A355B415-64D9-4D85-A4A7-E5E24D0D66DA Q38945643-48F91E25-808C-4318-855E-18FD3CB4C012 Q46236716-C1233D98-5E06-4AE8-9994-C92C69E9A687 Q47921833-876C01FA-7274-4CB6-97C5-1ABA90C2959C Q58798935-C95E4244-E000-4461-8510-DA0C2BB80B76

P2860

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

http://www.wikidata.org/entity/Q34961901

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@ast

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@en

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@nl

type

label

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@ast

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@en

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@nl

prefLabel

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@ast

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@en

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@nl

P1433

Q34961901-69C7A161-218C-431F-B7D2-6C7AAD75CA8D

P1476

Q34961901-3903D0CF-54AF-4BF4-8D94-8C28E3ADB54D

P2093

Q34961901-0E795105-5AD0-4CD8-AED0-E31D213D38D5

Q34961901-0F023460-B72D-4374-8CD8-FC65881D2FA2

Q34961901-58555A7A-5663-46D5-82EE-8307E938224E

P275

Q34961901-D0D441ED-1B1E-4956-BC05-01C86D06CD4C

P2860

Q34961901-060F759C-8631-4719-AFED-51D8DFBB4672

Q34961901-06495038-7926-49E5-BE57-B5C414E180D6

Q34961901-0B37C5F4-009A-4417-B229-5A89B006706D

Q34961901-142C700B-0729-4DD5-99AA-1505EEFFFE8C

Q34961901-19A3F313-33D8-4DFF-B470-B222897AA44C

Q34961901-1A33D710-3FDE-47EC-AB81-EC6572520B67

Q34961901-24105D42-AA4B-4FB7-BD75-C8673F2B97F2

Q34961901-2519A936-242F-47D2-BF2C-C80A3EEF4F80

Q34961901-25723599-8D6B-4175-A1F9-CD5C9FC60590

Q34961901-2857477C-E55B-4F40-B8E8-72702AF60272

P2888

Q34961901-04805607-4492-4637-984F-7C58214525F4

P304

Q34961901-71BB726C-D732-45F8-A5A1-897A434986AF

P31

Q34961901-598488B7-8B93-4D32-BE72-06509579EB98

Q34961901-9AD7A35E-0238-4DB2-8DB4-2B6E9A46C6AE

P356

Q34961901-9E48B3D2-09CA-40D4-935C-CA2110832C13

P478

Q34961901-36E879AB-CF3B-437A-AA8F-F3E1B2A1CF13

P577

Q34961901-E67E1BCA-D57B-49F5-94F6-273133447111

P5875

Q34961901-35CBDE75-F210-439E-B69C-3EC60E97ACB3

P6179

Q34961901-7211D2D7-8878-4FE3-9399-427F5CF8734D

P698

Q34961901-06F6FB03-52EA-442D-B7B3-50B5F3643C31

P921

Q34961901-2A724EE6-DA0A-4D02-B3FE-DAC152C1A676

Q34961901-5310ACA7-A199-4759-A5D6-A281DCA0E655

Q34961901-9793DE8D-F8A5-46EA-925A-BCCD7C7FCDD4

Q34961901-D5FF5BC7-81DE-44AA-881C-7741966C55E5

Q34961901-F4534870-5A7C-4138-B5D9-A4477E40E6B2

P932

Q34961901-342A6328-DC70-4930-A9F4-2CF55BAF6019

P356

1465-9921-12-45

P1433

Respiratory Research

P1476

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

@en

P2093

Dongmei Wu

http://www.w3.org/2001/XMLSchema#string

Dongwon Lee

http://www.w3.org/2001/XMLSchema#string

Yong Kiel Sung

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways

Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes

Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP

Vasoactive intestinal peptide: cardiovascular effects.

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs.

Vasoactive intestinal peptide, a singlet oxygen quencher.

Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?

Vasoactive intestinal peptide in human nasal mucosa

Vasoactive intestinal polypeptide as mediator of asthma.

P2888

1465-9921-12-45

P304

45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-12-45

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51036426

http://www.w3.org/2001/XMLSchema#string

P6179

1039681054

http://www.w3.org/2001/XMLSchema#string

P698

21477377

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

nerve tissue proteins

P932

3090995

http://www.w3.org/2001/XMLSchema#string